35 results on '"Weisshaar, E."'
Search Results
2. [Hand eczema or psoriasis: update on the FB 323 study occupational dermatology cohort].
- Author
-
Bentz P, Eyerich K, Skudlik C, Schröder-Kraft C, Löffler H, Pföhler C, Leitz R, Thölken K, and Weisshaar E
- Subjects
- Humans, Middle Aged, Retrospective Studies, Dermatitis, Occupational diagnosis, Dermatology, Hand Dermatoses diagnosis, Eczema diagnosis, Psoriasis diagnosis
- Abstract
In daily dermatological practice, the distinction between eczema and psoriasis in dermatoses of the hands can be difficult. However, a clear diagnosis is necessary to initiate optimal therapy and management. In recent years, the so-called molecular classifier has been developed for optimized differentiation of eczema and psoriasis. An occupational dermatological cohort has been established at Heidelberg University Hospital since 2020. It is funded by the German Statutory Accident Insurance. The aim is to follow-up patients over 3 years where this new diagnostic method is used and to compare the results with a retrospective occupational dermatological cohort. Recruitment ended in December 2022. The current analysis reports participants' occupational activity, insurance status, disease progression, and number of sick days. A total of 287 patients were included; mean age was 50.4 years and 63.5% (n = 181) were undergoing treatment at the expense of the liable statutory accident insurance at the start of the study. About 50% of the patients worked in health professions, metal industry, or construction. The average duration of occupational dermatosis was 6.5 years. In 38.9% of the patients, the clinical diagnosis had been classified as unclear by the treating dermatologist. By using the molecular classifier, the diagnosis could be clarified in 98% of the cases (eczema vs. psoriasis). The first analyses demonstrate that the molecular classifier contributes to improving therapy by optimizing the diagnosis., (© 2023. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
3. Contact sensitizations in massage therapists with occupational contact dermatitis: Patch test data of the Information Network of Departments of Dermatology, 2008-2020.
- Author
-
Brans R, Schröder-Kraft C, Bauer A, Weisshaar E, Skudlik C, and Geier J
- Subjects
- Humans, Patch Tests adverse effects, Retrospective Studies, Information Services, Massage, Allergens, Dermatitis, Occupational diagnosis, Dermatitis, Occupational epidemiology, Dermatitis, Occupational etiology, Dermatitis, Allergic Contact diagnosis, Dermatitis, Allergic Contact epidemiology, Dermatitis, Allergic Contact etiology, Dermatology, Perfume, Oils, Volatile adverse effects
- Abstract
Background: Massage therapists are particularly exposed to constituents of massage preparations, wet work and mechanical strain and therefore, at high risk to develop occupational dermatitis (OD)., Objectives: To describe the sensitization spectrum of massage therapists with OD., Patients and Methods: In a retrospective study, patch test data of patients with OD (128 massage therapists and 24 374 patients working in other professions) collected by the Network of Departments of Dermatology (IVDK, 2008-2020) were analysed., Results: Hand dermatitis (91.4%) and allergic contact dermatitis (34.4%) were common in massage therapists with OD. Most frequent were sensitizations to fragrances/essential oils which were found in 54 (42.2%) massage therapists and thus, more often than in other patients with OD. Concomitant positivity to several fragrances/essential oils was frequent. In 8 (14.8%) of the 54 massage therapists, sensitizations to fragrances/essential oils were not detected with the baseline series, but only with special fragrance series., Conclusions: Allergic contact dermatitis is common in massage therapists with OD and is mainly caused by fragrances and essential oils. Hence, massage therapists should be aware of this risk. When OD is suspected, not only the baseline series, but also special fragrance series should be patch tested in this occupational group., (© 2022 The Authors. Contact Dermatitis published by John Wiley & Sons Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
4. [Pitfalls in occupational dermatology].
- Author
-
Steffens E, Zeidan H, and Weisshaar E
- Subjects
- Humans, Dermatitis, Atopic diagnosis, Dermatitis, Atopic epidemiology, Dermatitis, Occupational diagnosis, Dermatitis, Occupational epidemiology, Dermatology, Eczema, Hand Dermatoses diagnosis, Hand Dermatoses epidemiology, Hand Dermatoses therapy
- Abstract
Occupational dermatology has become a vibrant and interesting specialty, particularly in recent years. This includes more than hand eczema (HE). The increasing prevalence of atopic dermatitis (AD) has led to an increase of atopic hand eczema which can be worsened in certain occupations. New systemic therapies have improved the range of treatments for HE. The current guideline on hand eczema includes a variety of topical and systemic therapies. Nevertheless, in daily occupational dermatological practice, there are still chronic cases, especially vesicular hand eczema. They can often not be assigned to a clear cause, which is often a problem for those who are affected. In addition, co-factors such as chronic infectious comorbidities and psychological factors/illnesses must be considered. We present challenges in occupational dermatology by reporting special cases.
- Published
- 2021
- Full Text
- View/download PDF
5. [Occupational dermatology-more relevant than ever].
- Author
-
Weisshaar E and John SM
- Subjects
- Humans, Dermatitis, Occupational diagnosis, Dermatitis, Occupational etiology, Dermatitis, Occupational prevention & control, Dermatology, Occupational Medicine
- Published
- 2021
- Full Text
- View/download PDF
6. Which outcomes have been measured in hand eczema trials? A systematic review.
- Author
-
Rönsch H, Apfelbacher C, Brans R, Matterne U, Molin S, Ofenloch R, Oosterhaven JAF, Schuttelaar MLA, Weisshaar E, Yew YW, and Bauer A
- Subjects
- Clinical Trials as Topic, Controlled Clinical Trials as Topic, Humans, Patient Reported Outcome Measures, Symptom Assessment, Dermatitis, Atopic, Dermatology standards, Eczema, Outcome Assessment, Health Care standards, Severity of Illness Index
- Abstract
The considerable heterogeneity of outcomes and measurement instruments in hand eczema trials substantially limits the evidence synthesis concerning therapeutic and preventive interventions. Therefore, the Hand Eczema Core Outcome Set (HECOS) initiative is developing a core outcome set for future trials. The first objective was to identify outcomes that were measured in previous trials, to group them in domains, and to identify their measurement instruments. We conducted a systematic review of controlled and randomized controlled hand eczema trials published since 2000. Sixty-one eligible studies were identified. Each assessed one or more of 47 outcomes in the "skin" domain. Eighteen trials (30%) additionally focused on preventive behaviour in risk occupations. Quality of life was measured in 13 studies (21%). Thirty-two distinct named instruments were applied, but 223 measurements (62%) were conducted with unnamed instruments. Only 32 studies (52%) defined a primary outcome. Twenty-nine trials (48%) provided some information on adverse events, but none gave any references concerning relevant methods. Our review confirms the need to harmonize outcome measurements in hand eczema trials. The findings form the basis for a consensus process to generate a core outcome set to improve the explanatory power and comparability of future hand eczema studies., (© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
- Published
- 2019
- Full Text
- View/download PDF
7. European S2k Guideline on Chronic Pruritus.
- Author
-
Weisshaar E, Szepietowski JC, Dalgard FJ, Garcovich S, Gieler U, Giménez-Arnau AM, Lambert J, Leslie T, Mettang T, Misery L, Şavk E, Streit M, Tschachler E, Wallengren J, and Ständer S
- Subjects
- Chronic Disease, Europe epidemiology, Humans, Incidence, Predictive Value of Tests, Pruritus diagnosis, Pruritus epidemiology, Risk Factors, Treatment Outcome, Dermatology standards, Pruritus therapy
- Abstract
Pruritus is a frequent symptom in medicine. Population-based studies show that every 5th person in the general population has suffered from chronic pruritus at least once in the lifetime with a 12-month incidence of 7%. In patient populations its frequency is much higher depending on the underlying cause, ranging from around 25% in haemodialysis patients to 100% in skin diseases such as urticaria and atopic dermatitis (AD). Pruritus may be the result of a dermatological or non-dermatological disease. Especially in non-diseased skin it may be caused by systemic, neurological or psychiatric diseases, as well as being a side effect of medications. In a number of cases chronic pruritus may be of multifactorial origin. Pruritus needs a precise diagnostic work-up. Management of chronic pruritus comprises treatment of the underlying disease and topical treatment modalities, including symptomatic antipruritic treatment, ultraviolet phototherapy and systemic treatment. Treating chronic pruritus needs to be targeted, multimodal and performed in a step-wise procedure requiring an interdisciplinary approach. We present the updated and consensus based (S2k) European guideline on chronic pruritus by a team of European pruritus experts from different disciplines. This version is an updated version of the guideline that was published in 2012 and updated in 2014 (www.euroderm.org).
- Published
- 2019
- Full Text
- View/download PDF
8. [Tropical dermatology: more important than ever].
- Author
-
Weisshaar E and Reinel D
- Subjects
- Humans, Dermatology trends, Skin Diseases diagnosis, Skin Diseases therapy, Travel, Tropical Climate, Tropical Medicine trends
- Published
- 2014
- Full Text
- View/download PDF
9. Cooperation between the occupational health insurance and physicians practicing occupational dermatology: optimization potential in quality assurance.
- Author
-
Elsner P, Aberer W, Bauer A, Diepgen TL, Drexler H, Fartasch M, John SM, Schuhmacher-Stock U, Wehrmann W, and Weisshaar E
- Subjects
- Attitude of Health Personnel, Cost-Benefit Analysis, Data Collection, Dermatitis, Occupational economics, Female, Germany, Hand Dermatoses economics, Health Services Research, Humans, Male, Middle Aged, Specialization, Workers' Compensation economics, Cooperative Behavior, Dermatitis, Occupational therapy, Dermatology economics, Hand Dermatoses therapy, Health Benefit Plans, Employee economics, Interdisciplinary Communication, National Health Programs economics, Occupational Medicine economics, Quality Assurance, Health Care economics
- Abstract
Background: Quality assurance is a task of the medical profession, but it is also a duty of the occupational health insurance (OHI). Data on the interaction quality between physicians practicing occupational dermatology and the OHI are limited., Material and Methods: An online survey was performed in 854 German members of the Working Group on Occupational and Environmental Dermatology in October 2013. Items included demographic data, a judgment on the cooperation between the dermatologists and OHI companies, an economic grading of the current compensation scheme, and prioritization of optimization tasks., Results: 182 members (21.3 % of the invited population) participated in the survey. The cooperation with the OHI companies was judged as "very good" by 10.8 %, as "good" by 56.7 %, as "satisfactory" by 24.2 %, as "sufficient" by 7.0 % and as "inadequate" by 1.3 %. 93.4 % of the interviewed mentioned problems and improvement potentials in the cooperation of their practice or clinic with OHI companies. Main points of criticisms were reimbursement (44.7 %), followed by impairments of the treatment options (36.5 %) and the delay or scope of the treatment in the dermatologist's procedure (29.4 %)., Conclusions: While most physicians practicing occupational dermatology give a positive judgment of their cooperation with OHI companies, quality optimization potentials exist regarding the reimbursement of dermatological services, especially regarding time-intensive counselling in the prevention of occupational skin diseases, in the enablement of diagnostic and therapeutic procedures according to current guidelines and in a timely preventive intervention to use the therapeutic window before chronification of skin diseases may occur., (© 2014 Deutsche Dermatologische Gesellschaft (DDG). Published by John Wiley & Sons Ltd.)
- Published
- 2014
- Full Text
- View/download PDF
10. [S2k guideline--Chronic Pruritus].
- Author
-
Ständer S, Darsow U, Mettang T, Gieler U, Maurer M, Ständer H, Beuers U, Niemeier V, Gollnick H, Vogelgsang M, and Weisshaar E
- Subjects
- Chronic Disease, Germany, Humans, Dermatologic Agents therapeutic use, Dermatology standards, Dermoscopy standards, Practice Guidelines as Topic, Pruritus diagnosis, Pruritus drug therapy
- Published
- 2012
- Full Text
- View/download PDF
11. European guideline on chronic pruritus.
- Author
-
Weisshaar E, Szepietowski JC, Darsow U, Misery L, Wallengren J, Mettang T, Gieler U, Lotti T, Lambert J, Maisel P, Streit M, Greaves MW, Carmichael AJ, Tschachler E, Ring J, and Ständer S
- Subjects
- Chronic Disease, Consensus, Europe, Humans, Predictive Value of Tests, Pruritus diagnosis, Pruritus epidemiology, Risk Factors, Dermatology standards, Pruritus therapy
- Published
- 2012
- Full Text
- View/download PDF
12. [Dermato-epidemiology].
- Author
-
Apfelbacher CJ, Diepgen TL, and Weisshaar E
- Subjects
- Epidemiologic Methods, Humans, Prevalence, Risk Assessment methods, Risk Factors, Data Interpretation, Statistical, Dermatology methods, Population Surveillance methods, Skin Diseases epidemiology
- Abstract
Dermato-epidemiology is an important scientific discipline which investigates skin diseases using epidemiological methods. Epidemiology is the science of the distribution and determinants of disease in specified populations. We describe fundamental terms of dermato-epidemiology (measures of disease occurrence, measures of risk), different study types (observational studies, interventional studies), the selection of statistical tests, bias and confounding as well as the principles of evidence-based dermatology, and give illustrative examples.
- Published
- 2011
- Full Text
- View/download PDF
13. CARPE: a registry project of the German Dermatological Society (DDG) for the characterization and care of chronic hand eczema.
- Author
-
Apfelbacher CJ, Akst W, Molin S, Schmitt J, Bauer A, Weisshaar E, Mahler V, Treichel S, Ruzicka T, Luger T, Elsner P, and Diepgen TL
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Chronic Disease, Dermatitis, Occupational diagnosis, Dermatitis, Occupational etiology, Dermatitis, Occupational therapy, Eczema etiology, Female, Germany, Hand Dermatoses etiology, Humans, Male, Middle Aged, Prospective Studies, Risk Factors, Young Adult, Dermatology, Eczema diagnosis, Eczema therapy, Hand Dermatoses diagnosis, Hand Dermatoses therapy, Registries, Societies, Medical
- Abstract
Background: The aim of the CARPE (German acronym: Chronisches Handekzem-Register zum Patienten-Langzeitmanagement; meaning: chronic hand eczema registry on long-term patient management) registry is to investigate characteristics and treatment modalities in patients affected by chronic hand eczema in Germany., Methods: The registry was built up under the auspices of the German Dermatological Society (Deutsche Dermatologische Gesellschaft, DDG). Patients with chronic hand eczema are prospectively assessed by dermatological examination and patient questionnaire. Socio-economic data and data on diagnostics, skin status, severity and treatment of chronic hand eczema and atopy criteria are repeatedly assessed. Here, we present baseline characteristics of the first 515 patients., Results: 53.8 % of the patients were female, mean age was 47.3 years. The average duration of CHE was 7.7 years. 30.4 % had already received inpatient care, 31.2 % had been on sick leave in the past 12 months. 94.5 % had received topical corticosteroids prior to inclusion in the registry, 31.9 % topical calcineurin inhibitors, 38.3 % UV therapy, 28.6 % systemic antihistamines, 36.5 % systemic treatments, 14.9 % systemic corticosteroids, 25.8 % systemic retinoids., Conclusions: The CARPE project demonstrates the high medical burden and therapeutic challenge of chronic hand eczema and presents first data for health care research. Furthermore, the designed follow-up study will present important data about the natural history and prognosis of this chronic skin disease., (© The Authors • Journal compilation © Blackwell Verlag GmbH, Berlin.)
- Published
- 2011
- Full Text
- View/download PDF
14. [Medical information systems in the internet : current data about the dermatologic web site www.dermis.net].
- Author
-
Diepgen TL, Tanko Z, Weisshaar E, Matvijets A, and Simon M
- Subjects
- Computer-Assisted Instruction, Humans, Skin Diseases etiology, Skin Diseases therapy, Skin Neoplasms etiology, Skin Neoplasms therapy, Software, Dermatology education, Information Systems, Internet, Knowledge Bases, Skin Diseases diagnosis, Skin Neoplasms diagnosis
- Abstract
www.dermis.net was established in 1994 as a dermatological information system with now more than 4,000 pages and over 7,500 dermatological images in an atlas. 1,200 dermatological diagnoses and medical information with 1,100 synonyms can be searched by body location and in alphabetical order. Additionally, there are seven information modules about skin cancer, atopic dermatitis, rosacea, skin care, eczema, fungal diseases and hemorrhoids with links to other medical pages like Cochrane Library. Pediatric skin diseases are covered in PeDOIA. www.dermis.net is meanwhile available in German, English, Spanish, Portuguese, French and Turkish language. Current contents of this information system and user behavior are presented in this paper.
- Published
- 2009
- Full Text
- View/download PDF
15. [Historical aspects concerning the symptom of itch in the German-speaking region (1850-1939)].
- Author
-
Weisshaar E, Grüll V, Diepgen TL, and Eckart WU
- Subjects
- Germany, History, 19th Century, History, 20th Century, Humans, Dermatology history, Pruritus diagnosis, Pruritus history
- Abstract
Since the establishment of dermatology as an independent discipline of medicine in the middle of the 19th century, pruritus or itch has been a subject of research. The goals were to discover the etiology of pruritus, to develop useful therapies and to achieve a classification within the system of skin diseases. Looking at historical aspects of pruritus demonstrates just how difficult it has been to approach this problem. The difficulties even influence present day pruritus research. For example, there is no definite international standard of pruritus. Etiology-oriented classifications have dominated, but have recently been supplemented by a clinical classification.
- Published
- 2009
- Full Text
- View/download PDF
16. [4th International Workshop for the Study of Itch vom 9.-11.9.2007 in San Francisco].
- Author
-
Gieler U, Weisshaar E, Carstens E, Yosipovitch G, and Ständer S
- Subjects
- Humans, Pruritus physiopathology, Biomedical Research, Clinical Trials as Topic trends, Dermatology trends, Pruritus diagnosis, Pruritus therapy
- Published
- 2008
- Full Text
- View/download PDF
17. [Report on the International Workshop for the Study of Itch in Singapore 5-7 October 2001].
- Author
-
Weisshaar E and Gieler U
- Subjects
- Humans, Singapore, Dermatology, Education, Pruritus
- Published
- 2002
- Full Text
- View/download PDF
18. Implementation of dupilumab in routine care of atopic eczema: results from the German national registry <scp>TREAT</scp> germany
- Author
-
Abraham, S., Haufe, E., Harder, I., Heratizadeh, A., Kleinheinz, A., Wollenberg, A., Weisshaar, E., Augustin, M., Wiemers, F., Zink, A., Biedermann, T., von Kiedrowski, R., Hilgers, M., Worm, M., Pawlak, M., Sticherling, M., Fell, I., Handrick, C., Schäkel, K., Staubach, P., Asmussen, A., Schwarz, B., Bell, M., Neubert, K., Effendy, I., Bieber, T., Homey, B., Gerlach, B., Tchitcherina, E., Stahl, M., Schwichtenberg, U., Rossbacher, J., Buck, P., Mempel, M., Beissert, S., Werfel, T., Weidinger, S., Schmitt, J., and TREATgermany study group
- Subjects
medicine.medical_specialty ,business.industry ,Eczema ,MEDLINE ,Dermatology ,Antibodies, Monoclonal, Humanized ,Dupilumab ,language.human_language ,Dermatitis, Atopic ,German ,Family medicine ,language ,Humans ,Medicine ,Registries ,National registry ,business ,Routine care - Abstract
The German atopic eczema (AE)-registry TREATgermany is a non-interventional multicenter patient cohort study for adult patients with currently moderate-to-severe disease activity or current/previous anti-inflammatory systemic treatment.1,2 Dupilumab has demonstrated to be an effective treatment for patients with moderate-to-severe AE in clinical trials.3-5 Real world evidence is now needed to evaluate its effectiveness and safety in routine care.
- Published
- 2020
19. Pruritus, Erytheme & Co: Das Ohr aus dermatologischer Sicht
- Author
-
Weisshaar, E., Kallen, U., Klintworth, N., and Zenk, J.
- Published
- 2011
- Full Text
- View/download PDF
20. Pathophysiology and management of sensitive skin: position paper from the special interest group on sensitive skin of the International Forum for the Study of Itch (IFSI)
- Author
-
Misery, L., Weisshaar, E., Brenaut, E., Evers, A.W.M., Huet, F., Ständer, S., Reich, A., Berardesca, E., Serra‐Baldrich, E., Wallengren, J., Linder, D., Fluhr, J.W., Szepietowski, J.C., Maibach, H., Honari, Golara, Le Gall‐Ianotto, Christelle, Takamori, Kenji, Richters, Renée, Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), and Université de Brest (UBO)
- Subjects
medicine.medical_specialty ,Skin barrier ,media_common.quotation_subject ,[SDV]Life Sciences [q-bio] ,Pain ,Dermatology ,Cosmetics ,Skin Diseases ,Sensitive skin ,030207 dermatology & venereal diseases ,03 medical and health sciences ,0302 clinical medicine ,[SDV.BC.IC]Life Sciences [q-bio]/Cellular Biology/Cell Behavior [q-bio.CB] ,medicine ,Humans ,Paresthesia ,ComputingMilieux_MISCELLANEOUS ,media_common ,integumentary system ,business.industry ,Pruritus ,[SDV.BBM.BM]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Molecular biology ,[SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/Hematology ,Pathophysiology ,3. Good health ,Clinical trial ,Infectious Diseases ,Public Opinion ,Position paper ,Tingling ,business ,Psychosocial ,030217 neurology & neurosurgery ,[SDV.MHEP.DERM]Life Sciences [q-bio]/Human health and pathology/Dermatology - Abstract
The special interest group on sensitive skin of the International Forum for the Study of Itch previously defined sensitive skin as a syndrome defined by the occurrence of unpleasant sensations (stinging, burning, pain, pruritus and tingling sensations) in response to stimuli that normally should not provoke such sensations. This additional paper focuses on the pathophysiology and the management of sensitive skin. Sensitive skin is not an immunological disorder but is related to alterations of the skin nervous system. Skin barrier abnormalities are frequently associated, but there is no cause and direct relationship. Further studies are needed to better understand the pathophysiology of sensitive skin - as well as the inducing factors. Avoidance of possible triggering factors and the use of well-tolerated cosmetics, especially those containing inhibitors of unpleasant sensations, might be suggested for patients with sensitive skin. The role of psychosocial factors, such as stress or negative expectations, might be relevant for subgroups of patients. To date, there is no clinical trial supporting the use of topical or systemic drugs in sensitive skin. The published data are not sufficient to reach a consensus on sensitive skin management. In general, patients with sensitive skin require a personalized approach, taking into account various biomedical, neural and psychosocial factors affecting sensitive skin.
- Published
- 2020
21. Chronic nodular prurigo: clinical profile and burden. A European cross-sectional study
- Author
-
Pereira, M. P., Hoffmann, V., Weisshaar, E., Wallengren, J., Halvorsen, J. A., Garcovich, Simone, Misery, L., Brenaut, E., Savk, E., Potekaev, N., Lvov, A., Bobko, S., Szepietowski, J. C., Reich, A., Bozek, A., Legat, F. J., Metz, M., Streit, M., Serra-Baldrich, E., Goncalo, M., Storck, M., Greiwe, I., Nau, T., Steinke, S., Dugas, M., Stander, S., Zeidler, C., Dalgard, F., Elberling, J., Forner, C., Leslie, T., Riepe, C., Schneider, G., and Stander, H.
- Subjects
0301 basic medicine ,Male ,medicine.medical_specialty ,pruritus ,outcome measures ,Patient Reported Outcome Measures ,Outcome Assessment, Health Care ,prurigo ,comorbidity ,Cross-sectional study ,Dermatology ,Disease ,030207 dermatology & venereal diseases ,03 medical and health sciences ,0302 clinical medicine ,Quality of life ,Internal medicine ,Medicine ,Humans ,In patient ,Sensory symptoms ,Chronic itch ,business.industry ,Pruritus ,Middle Aged ,medicine.disease ,Europe ,030104 developmental biology ,Infectious Diseases ,Cross-Sectional Studies ,Chronic Disease ,Quality of Life ,Prurigo ,Nodular prurigo ,Settore MED/35 - MALATTIE CUTANEE E VENEREE ,business ,Prurigo nodularis - Abstract
Background Chronic nodular prurigo (CNPG) is a condition characterized by chronic itch, a prolonged scratching behaviour and the presence of pruriginous nodules. A comprehensive understanding of this condition, especially regarding its clinical characteristics and impact on quality of life is still lacking. Objectives Aim of this pan-European multicentre cross-sectional study was to establish the clinical profile of CNPG, including its associated burden. Methods Fifteen centres from 12 European countries recruited CNPG patients presenting at the centre or using the centres' own databases. Patients were asked to complete a questionnaire in paper or electronic format. Demography, current co-morbidities, underlying disease, itch intensity, additional sensory symptoms, quality of life, highest burden and emotional experience of itch were assessed. Results A total of 509 patients (210 male, median age: 64 years [52; 72]) were enrolled. Of these, 406 reported itch and CNPG lesions in the previous 7 days and qualified to complete the whole questionnaire. We recorded moderate to severe worst itch intensity scores in the previous 24 h. Scores were higher in patients with lower educational levels and those coming from Eastern or Southern Europe. Most patients experience itch often or always (71%) and report that their everyday life is negatively affected (53%). Itch intensity was considered to be the most burdensome aspect of the disease by 49% of the patients, followed by the visibility of skin lesions (21%) and bleeding of lesions (21%). The majority of patients was unaware of an underlying condition contributing to CNPG (64%), while psychiatric diseases were the conditions most often mentioned in association with CNPG (19%). Conclusions This multicentre cross-sectional study shows that itch is the dominant symptom in CNPG and reveals that the profile of the disease is similar throughout Europe.
- Published
- 2020
22. Position Statement: Linear prurigo is a subtype of chronic prurigo
- Author
-
Pereira, M. P., Zeidler, C., Nau, T., Bobko, S., Evers, A. W. M., Garcovich, Simone, Goncalo, M., Halvorsen, J. A., Lambert, J., Legat, F. J., Leslie, T., Metz, M., Misery, L., Nordlind, K., Reich, A., Schneider, G., Stander, H., Streit, M., Szepietowski, J. C., Wallengren, J., Weisshaar, E., Stander, S., Augustin, M., Brenaut, E., Dalgard, F. J., Elberling, J., Gieler, U., Kupfer, J., Lvov, A., Mittal, A., Savk, E., Serra-Baldrich, E., Steinke, S., Tschachler, E., Weller, K., and EADV Task Force Pruritus
- Subjects
0301 basic medicine ,Position statement ,Male ,medicine.medical_specialty ,Consensus ,Dermatology ,Disease ,Diagnosis, Differential ,030207 dermatology & venereal diseases ,03 medical and health sciences ,Therapeutic approach ,0302 clinical medicine ,Prurigo ,Diagnosis ,medicine ,Humans ,Chronic prurigo ,integumentary system ,business.industry ,Pruritus ,Consensus conference ,medicine.disease ,Factitious disorder ,030104 developmental biology ,Infectious Diseases ,CpG site ,Differential ,Chronic Disease ,Practice Guidelines as Topic ,Inflammatory diseases Radboud Institute for Health Sciences [Radboudumc 5] ,Female ,Human medicine ,Dermatologic Agents ,Settore MED/35 - MALATTIE CUTANEE E VENEREE ,business - Abstract
BackgroundChronic prurigo (CPG) is a distinct disease characterized by chronic pruritus, history and/or signs of prolonged scratching and multiple pruriginous lesions. It may present with various clinical manifestations, including papules, nodules, plaques or umbilicated lesions. Some patients with chronic pruritus show pruriginous linear and scaring scratch lesions (LSSL) and it is unclear whether these lesions belong to the spectrum of CPG. Objective To achieve a consensus on the classification of pruriginous LSSL and establish criteria to differentiate them from similar appearing conditions of different nature.Methods Members of the Task Force Pruritus (TFP) of the European Academy of Dermatology and Venereology participated in the consensus conference, discussing representative clinical cases. Using the Delphi method, consensus was reached when ≥75% of members agreed on a statement.Results Twenty‐one members of the TFP with voting rights participated in the meeting. It was consented that LSSL occurs due to chronic pruritus and prolonged scratching, and share common pathophysiological mechanisms with CPG. LSSL were thus considered as belonging to the spectrum of CPG and the term ‘linear prurigo’ was chosen to describe this manifestation.Conclusion Considering linear prurigo as belonging to the spectrum of CPG has important clinical implications, since both the diagnostic and therapeutic approach of these patients should be performed as recommended for CPG. Importantly, linear prurigo should be differentiated from self‐inflicted skin lesions as factitious disorders or skin picking syndromes. In the latter, artificial manipulation rather than pruritus itself leads to the development of cutaneous lesions, which can show clinical similarities to linear prurigo.
- Published
- 2018
23. Major Role for TRPV1 and InsP3R in PAR2-Elicited Inflammatory Mediator Production in Differentiated Human Keratinocytes
- Author
-
Misery, Laurent, Brenaut, Emilie, Pierre, Ophélie, Le Garrec, Raphaele, Gouin, Olivier, Lebonvallet, Nicolas, Abasq‐Thomas, Claire, Talagas, Matthieu, Le Gall‐Ianotto, Christelle, Besner‐Morin, Catherine, Fluhr, Joachim, Leven, Cyril, Chéret, Jérémy, Ponce, Leslie, Bertolini, Marta, Paus, Ralf, L’Herondelle, Killian, Fouyet, Sophie, Leschiera, Raphael, Le Gall-Ianotto, Christelle, Philippe, Reginald, Buscaglia, Paul, Mignen, Olivier, Lewis, Richard, Michel, Laurence, Devergne, C., Kerspern, H., Poizeau, F., Eveillard, J.R., Carré, J.L., Weisshaar, E., Evers, A.W.M., Huet, F., Ständer, S., Reich, A., Berardesca, E., Serra‐Baldrich, E., Wallengren, J., Linder, D., Fluhr, J.W., Szepietowski, J.C., Maibach, H., Honari, Golara, Takamori, Kenji, Richters, Renée, Barnetche, T., Roudot, A.‐C., Ficheux, A.‐S., Le Calloch, Ronan, Couturier, Marie‐Anne, Chauveau, Aurélie, Lippert, Eric, Carré, Jean‐Luc, Ianotto, Jean‐Christophe, Bataille, Adeline, Genin, Emmanuelle, L'Herondelle, Killian, Legoux, Nelig, Buhé, Virginie, Sakka, Mehdi, Kerfant, Nathalie, Carré, Jean-Luc, Lefeuvre, Luc, Université de Brest (UBO), Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), and Laboratoire sur les interactions Epithéliums Neurones (LIEN)
- Subjects
0301 basic medicine ,Keratinocytes ,ORAI1 Protein ,[SDV]Life Sciences [q-bio] ,Primary Cell Culture ,TRPV Cation Channels ,Inflammation ,Dermatitis ,Dermatology ,Biochemistry ,Receptors, G-Protein-Coupled ,03 medical and health sciences ,chemistry.chemical_compound ,[SDV.BC.IC]Life Sciences [q-bio]/Cellular Biology/Cell Behavior [q-bio.CB] ,medicine ,Humans ,Inositol 1,4,5-Trisphosphate Receptors ,Receptor, PAR-2 ,Calcium Signaling ,RNA, Small Interfering ,Molecular Biology ,ComputingMilieux_MISCELLANEOUS ,Calcium signaling ,Phospholipase C ,ORAI1 ,NF-κB ,[SDV.BBM.BM]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Molecular biology ,[SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/Hematology ,Cell Differentiation ,Cell Biology ,Inositol trisphosphate receptor ,Cell biology ,030104 developmental biology ,medicine.anatomical_structure ,chemistry ,Tumor necrosis factor alpha ,medicine.symptom ,Inflammation Mediators ,Keratinocyte ,Oligopeptides ,[SDV.MHEP.DERM]Life Sciences [q-bio]/Human health and pathology/Dermatology - Abstract
PAR2 activation in basal keratinocytes stimulates inflammation via the Ca2+-dependent production of mediators such as IL-1β, TNF-α, and TSLP. In this study, we investigated PAR2 calcium signaling and the consequent production of inflammatory mediators in differentiated human primary keratinocytes (DhPKs). Stimulation with the PAR2-activating peptide SLIGKV promoted Ca2+ store depletion in both undifferentiated human primary keratinocytes and DhPKs. SLIGKV-evoked Ca2+ store depletion did not trigger the store-operated Ca2+ entry (i.e., SOCE) through ORAI1 in DhPKs compared with undifferentiated human primary keratinocytes. The inhibition of phospholipase C and the concomitant inhibition of TRPV1 and inositol triphosphate receptor in DhPKs abrogated the SLIGKV-evoked Ca2+ store depletion; NF-κB activity; and the production of inflammatory mediators such as IL-1β, TNF-α, and TSLP. Taken together, these results indicate a key role for both InsP3R and TRPV1 in Ca2+ internal stores in the PAR2-evoked Ca2+ release and consequent skin inflammation in DhPKs. These findings may provide clues to understanding the pathological role of DhPKs in skin disorders in which PAR2 is known to be involved, such as atopic dermatitis, Netherton syndrome, and psoriasis.
- Published
- 2017
24. Auswirkungen berufsbedingter Kontaktallergien gegen Methylisothiazolinon (MI), Benzisothiazolinon (BIT) und/oder Octylisothiazolinon (OIT) bei der BK 5101
- Author
-
Geier, Johannes, Werfel, Th., Becker, D., Dickel, H., Fartasch, M., Häberle, M., Hillen, Uwe, John, S.M., Mahler, V., Skudlik, Chr., Weisshaar, E., Zagrodnik, F., Diepgen, T.L., and John, SM.
- Subjects
Public Health, Environmental and Occupational Health ,Medizin ,Immunology and Allergy ,Dermatology - Abstract
These recommendations help to assess the impact of an occupationally acquired contact allergy to methylisothiazolinone (MI), benzisothiazolinone (BIT) and/or octylisothiazolinone (OIT) on the reduction of the earning capacity in cases of occupational skin disease according to No. 5101 of the German list of occupational diseases. All of these isothiazolinones are most frequently used in paints and varnishes, and less frequently in printing inks and metalworking fluids. Additionally, MI and BIT serve as preservatives in cleaning agents, and MI in cosmetics and body care products. BIT and OIT are used in adhesives and as components of wood protection and anti-fouling products. Occupations concerned are producers of paints, varnishes and printing inks, painters, printers and metalworkers. Impact of an occupationally acquired sensitization to MI, BIT, and/or OIT typically is low, because patients are not inevitably excluded from all of the above mentioned occupational fields. © 2013 Dustri-Verlag Dr. Karl Feistle.
- Published
- 2013
25. Berufsbedingte Kontaktallergie bei Maurern, Fliesenlegern und Angehörigen verwandter Berufe. Aktuelles Sensibilisierungsspektrum und Entwicklungen der letzten Jahre
- Author
-
Geier, J, Lessmann, H, Skudlik, C, Ballmer-Weber, B K, Weisshaar, E, Uter, W, Schnuch, A, and University of Zurich
- Subjects
Public Health, Environmental and Occupational Health ,10177 Dermatology Clinic ,Immunology and Allergy ,610 Medicine & health ,Dermatology - Published
- 2012
26. Auswirkung einer berufsbedingten Kontaktallergie gegen Methyldibromoglutaronitril bei der BK 5101
- Author
-
Dickel, H., Geier, J., Becker, D., Fartasch, M., Häberle, M., Hillen, Uwe, John, S.M., Mahler, V., Skudlik, C., Weisshaar, E., Werfel, T., Krohn, S., Diepgen, T.L., and John, SM.
- Subjects
Public Health, Environmental and Occupational Health ,Medizin ,Dermatology - Published
- 2015
27. Genitale Dermatologie
- Author
-
Weisshaar E, Schöfer H, and Lautenschlager S
- Subjects
medicine.medical_specialty ,business.industry ,Medicine ,Sex organ ,Dermatology ,business - Published
- 2014
28. The Quality of Life in Hand Eczema Questionnaire (QOLHEQ): validation of the German version of a new disease-specific measure of quality of life for patients with hand eczema.
- Author
-
Ofenloch, R.F., Weisshaar, E., Dumke, A.‐K., Molin, S., Diepgen, T.L., and Apfelbacher, C.
- Subjects
- *
QUALITY of life , *ECZEMA , *SKIN inflammation , *HAND diseases , *DERMATOLOGY - Abstract
Background Health-related quality of life ( HRQOL) is widely used as a patient-reported outcome to evaluate clinical trials. In routine care it can also be used to improve treatment strategies or to enhance patients' self-awareness and empowerment. Therefore a disease-specific instrument is needed that assesses in detail all the impairments caused by the disease of interest. For patients with hand eczema ( HE) such an instrument was developed by an international expert group, but its measurement properties are unknown. Objectives To validate the German version of the Quality of Life in Hand Eczema Questionnaire ( QOLHEQ), which covers the domains of (i) symptoms, (ii) emotions, (iii) functioning and (iv) treatment and prevention. Methods The QOLHEQ was assessed up to three times in 316 patients with HE to test reliability and sensitivity to change. To test construct validity we also assessed several reference measures. The scale structure was analysed using the Rasch model for each subscale and a structural equation model was used to test the multi domain structure of the QOLHEQ. Results After minor adaptions of the scoring structure, all four subscales of the QOLHEQ did not significantly misfit the Rasch model (α > 0·05). The fit indices of the structural equation model showed a good fit of the multi domain construct with four subscales assessing HRQOL. Nearly all a priori-defined hypotheses relating to construct validity could be confirmed. The QOLHEQ showed a sensitivity to change that was superior compared with all reference measures. Conclusions The QOLHEQ is ready to be used in its German version as a sensitive outcome measure in clinical trials and for routine monitoring. The treatment-relevant subscales enable its use to enhance patients' self-awareness and to monitor treatment decisions. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
29. Pruritus, Erytheme & Co.
- Author
-
Weisshaar, E., Kallen, U., Klintworth, N., and Zenk, J.
- Abstract
Copyright of HNO is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2011
- Full Text
- View/download PDF
30. Differential effects of a tertiary individual prevention programme for patients with occupational skin disease depending on diagnosis.
- Author
-
Matterne, U., Diepgen, T. L., and Weisshaar, E.
- Subjects
SKIN disease prevention ,PREVENTIVE medicine ,OCCUPATIONAL disease prevention ,OCCUPATIONAL health services ,DERMATOLOGY ,MEDICAL care ,HEALTH programs - Abstract
Background Occupational skin disease (OSD) is common. Tertiary individual prevention programmes (TIP) aim at helping individuals with refractory OSD to remain active in the workforce. Evidence exists that these interventions improve skin protection behaviour related cognitions. However, it is not clear whether these effects generalize to all types of OSD. Objective To evaluate whether effects on socio-cognitive determinants of skin protection behaviour vary between patients with work related atopic dermatitis (AD) and other work related skin diseases. Methods A total of 14 inpatients with work related AD and 87 inpatients with other work related skin diseases completed measures on socio-cognitive determinants of skin protection behaviour before and after a 3-week inpatient TIP. Mixed model analyses, using maximum-likelihood estimation tested whether there were differential effects of the intervention on socio-cognitive determinants of skin protection behaviour. Results Although patients with AD reported more favourable cognitions towards skin protection behaviour than patients with other skin diseases at admission, these cognitions deteriorated or remained on the same level. Patients with other forms of OSD on the other hand developed more favourable cognitions during the intervention. Conclusion Professionals working in the field of OSD should not cease to assist AD patients in achieving optimal skin protection behaviour. Tertiary individual prevention measures may need to pay more attention to the needs of individuals with an occupationally relevant AD. This may contribute to their being able to remain active in the workforce. The alternative would entail regular sick leave, poorer quality of life and economic hardship for the AD patient. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
31. Medizinische Informationssysteme im Internet.
- Author
-
Diepgen, T.L., Tanko, Z., Weisshaar, E., Matvijets, A., and Simon, M.
- Abstract
Copyright of Der Hautarzt is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2009
- Full Text
- View/download PDF
32. Pruritus as a leading symptom: clinical characteristics and quality of life in German and Ugandan patients.
- Author
-
Weisshaar, E., Apfelbacher, C., Jäger, G., Zimmermann, E., Bruckner, T., Diepgen, T. L., and Gollnick, H.
- Subjects
- *
ITCHING , *CUTANEOUS manifestations of general diseases , *SKIN diseases , *DERMATOLOGY - Abstract
Background Pruritus is the most frequent and distressing symptom associated with dermatoses and various internal and neurological diseases. Objectives To investigate two different populations of patients with pruritus, one in Germany and one in Uganda, with a particular focus on clinical characteristics, aetiology and quality of life. Methods We investigated by questionnaire 132 patients (59 men, 73 women, mean age 54·5 years) who were referred to the Department of Dermatology at the University Hospital of Magdeburg, Germany, with the diagnosis of pruritus as a leading symptom. The questionnaire was also applied in 84 patients who consulted the Dermatology Clinic at Mbarara, Uganda for pruritus. The questions referred to personal data and disease history of the individual, history and present occurrence of concomitant diseases, present and past therapy, quality, frequency and triggers of itching and scratching, other disorders and complaints, quality of life and impact on work and disability. Results Seventy-five (57%) of the German patients had pruritus due to dermatoses, 47 patients (36%) had pruritus due to a systemic disease and in 10 patients (8%) pruritus was of unknown origin. Most had a history of pruritus of several months up to years. Pruritus associated with dermatoses mostly affected the whole body and was permanent with an undulatory character. Affective reactions such as aggression and depression occurred more frequently in dermatological patients compared with those with systemic pruritus. The former group felt that pruritus had a greater impact on their lives. Almost all Ugandan patients had pruritus due to dermatoses except for three patients with pruritus of unknown origin. Eczema and prurigo were the most frequently observed dermatoses in both German and Ugandan patients. Patients with pruritus in both populations showed an impaired quality of life. There was no pronounced difference between the populations with regard to feelings of depression and suicidal thoughts. Conclusions A great deal of helpful information in this complex group of patients can be obtained using this questionnaire. Pruritus has a major impact on quality of life and especially impairs those patients with pruritus associated with dermatoses and pruritus of unknown origin. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
33. European Surveillance System on Contact Allergies (ESSCA): results with the European baseline series, 2013/14
- Author
-
Marie L A Schuttelaar, Mahbub M. U. Chowdhury, Andreas J. Bircher, Ian R. White, Anna Balato, Jeanne D. Johansen, Wolfgang Uter, Aleksandra Dugonik, S.M. John, S. M. Wilkinson, Magdalena Czarnecka-Operacz, Radoslaw Spiewak, Vera Mahler, Barbara Ballmer-Weber, Andreas Bauer, F. Larese Filon, J.C. Amario-Hita, Richard L. Gallo, Marta Kieć-Świerczyńska, Javier Sánchez-Pérez, Maria Pesonen, T. Kmecl, Dagmar Simon, Elke Weisshaar, A. Belloni Fortina, Susan Cooper, Anna Sadowska-Przytocka, Thomas Rustemeyer, Beata Kręcisz, Sibylle Schliemann, Skaidra Valiukevičienė, Ana Giménez-Arnau, Uter, W, Amario-Hita, Jc, Balato, A, Ballmer-Weber, B, Bauer, A, Belloni Fortina, A, Bircher, A, Chowdhury, Mmu, Cooper, Sm, Czarnecka-Operacz, M, Dugonik, A, Gallo, R, Giménez-Arnau, A, Johansen, Jd, John, Sm, Kieć-Świerczyńska, M, Kmecl, T, Kręcisz, B, Larese Filon, F, Mahler, V, Pesonen, M, Rustemeyer, T, Sadowska-Przytocka, A, Sánchez-Pérez, J, Schliemann, S, Schuttelaar, Ml, Simon, D, Spiewak, R, Valiukevičienė, S, Weisshaar, E, White, Ir, Wilkinson, Sm., Dermatology, AII - Inflammatory diseases, AII - Cancer immunology, Public Health Research (PHR), Amario Hita, J. C., Balato, A., Ballmer Weber, B., Bauer, A., Belloni Fortina, A., Bircher, A., Chowdhury, M. M. U., Cooper, S. M., Czarnecka Operacz, M., Dugonik, A., Gallo, R., Giménez Arnau, A., Johansen, J. D., John, S. M., Kieć Świerczyńska, M., Kmecl, T., Kręcisz, B., LARESE FILON, Francesca, Mahler, V., Pesonen, M., Rustemeyer, T., Sadowska Przytocka, A., Sánchez Pérez, J., Schliemann, S., Schuttelaar, M. L., Simon, D., Spiewak, R., Valiukevičienė, S., Weisshaar, E., White, I. R., Wilkinson, S. M., and University of Zurich
- Subjects
Male ,Pediatrics ,Allergy ,Allergic Contact ,Balsam of Peru ,PATCH TEST SERIES ,contact dermatitis ,030207 dermatology & venereal diseases ,chemistry.chemical_compound ,0302 clinical medicine ,Epidemiology ,Prevalence ,030212 general & internal medicine ,NETWORK ,610 Medicine & health ,PRESERVATIVES ,biology ,10177 Dermatology Clinic ,Patch test ,Heavy ,Middle Aged ,Adult ,Allergens ,Dermatitis, Allergic Contact ,Europe ,Female ,Humans ,Metals, Heavy ,Retrospective Studies ,Population Surveillance ,SENSITIZATION ,Infectious Diseases ,Metals ,FRAGRANCE MIX ,RUBBER SERIES ,epidemiology ,patch test ,medicine.medical_specialty ,RECOMMENDATION ,Myroxylon ,Dermatology ,Clinical surveillance ,2708 Dermatology ,03 medical and health sciences ,SPOT-TEST ,Methylisothiazolinone ,Environmental health ,medicine ,patch testing ,business.industry ,sensitisation ,Retrospective cohort study ,2725 Infectious Diseases ,biology.organism_classification ,medicine.disease ,DERMATITIS ,chemistry ,contact allergy ,business ,Contact dermatitis ,SKIN DISEASES - Abstract
BACKGROUND: Contact allergy is a common condition and can severely interfere with daily life or professional activities. Due to changes in exposures, a consequence of introduction of new substances, new products or formulations, and regulatory intervention, the spectrum of contact sensitisation changes. OBJECTIVE: To evaluate the current spectrum of contact allergy to allergens present in the European baseline series (EBS) across Europe. METHODS: Retrospective analysis of data collected by the European Surveillance System on Contact Allergies (ESSCA, www.essca-dc.org) in consecutively patch tested patients, 2013/14, in 46 departments in 12 European countries. RESULTS: Altogether, 31689 patients were included in the analysis. Compared to a similar analysis in 2004, the prevalence of contact allergy to methylisothiazolinone went up to around 20% in several departments. In comparison, contact allergy to the metals nickel, cobalt and chromium remained largely stable, at 18.1, 5.9 and 3.2%, respectively, similar to mostly unchanged prevalences with fragrance mix I, II and Myroxylon pereirae (Balsam of Peru) at 7.3, 3.8 and 5.3%, respectively. In the subgroup of departments diagnosing (mainly) patients with occupational contact dermatitis, the prevalence of work-related contact allergies such as to epoxy resin or rubber additives was increased, compared to general dermatology departments. CONCLUSION: Continuous surveillance of contact allergy based on network data offers the identification of time trends or persisting problems, and thus enables focussing in-depth research (subgroup analyses, exposure analysis) on areas where it is needed. This article is protected by copyright. All rights reserved.
- Published
- 2017
34. Formaldehyde 2% is not a useful means of detecting allergy to formaldehyde releasers- results of theESSCAnetwork, 2015-2018
- Author
-
Maria Pesonen, Anna Belloni Fortina, Ana Giménez-Arnau, Susan Cooper, Graham A. Johnston, Heinrich Dickel, Johannes Geier, Rosella Gallo, Elke Weisshaar, Magdalena Czarnecka-Operacz, Wolfgang Uter, Vera Mahler, Simon Dagmar, Heather Whitehouse, Barbara Ballmer-Weber, Andrea Bauer, Thomas Werfel, Thomas Rustemeyer, Skaidra Valiukevičienė, S. Mark Wilkinson, Marie L A Schuttelaar, Francesca Laresse Filon, Public Health Research (PHR), University of Zurich, Whitehouse, Heather, Whitehouse, H., Uter, W., Geier, J., Ballmer-Weber, B., Bauer, A., Cooper, S., Czarnecka-Operacz, M., Dagmar, S., Dickel, H., Fortina, A. B., Gallo, R., Gimenez-Arnau, A. M., Johnston, G. A., Filon, F. L., Mahler, V., Pesonen, M., Rustemeyer, T., Schuttelaar, M. L. A., Valiukeviciene, S., Weisshaar, E., Werfel, T., Wilkinson, M., Dermatology, and AII - Inflammatory diseases
- Subjects
Allergic Contact ,3-diol ,formaldehyde formaldehyde releaser ,2-bromo-2-nitropropane-1 ,Hydantoin ,Dermatitis ,Nitroparaffin ,CONTACT ALLERGY ,imidazolidinyl urea ,Gastroenterology ,DMDM hydantoin ,030207 dermatology & venereal diseases ,chemistry.chemical_compound ,2-bromo-2-nitropropane-1,3-diol ,contact allergy ,cosmetics ,diazolidinyl urea ,formaldehyde formaldehyde releasers ,quaternium-15 ,0302 clinical medicine ,Urea ,Immunology and Allergy ,030212 general & internal medicine ,610 Medicine & health ,PRESERVATIVES ,cosmetic ,RISK ,Patch Test ,Allergen ,10177 Dermatology Clinic ,Patch test ,Patch Tests ,Imidazolidinyl urea ,Dermatitis, Allergic Contact ,EUROPEAN SURVEILLANCE SYSTEM ,2723 Immunology and Allergy ,Human ,medicine.medical_specialty ,Formaldehyde ,Dermatology ,Nitroparaffins ,2708 Dermatology ,Propane ,03 medical and health sciences ,Internal medicine ,Quaternium-15 ,medicine ,Humans ,Allergens ,Diazolidinyl urea ,chemistry ,UREA - Abstract
BACKGROUND Studies suggest that patch testing with formaldehyde releasers (FRs) gives significant additional information to formaldehyde 1% aq. and should be considered for addition to the European baseline series (EBS). It is not known if this is also true for formaldehyde 2% aq. OBJECTIVES To determine the frequency of sensitization to formaldehyde 2% aq. and co-reactivity with FRs. To establish whether there is justification for including FRs in the EBS. MATERIALS AND METHODS A 4-year, multi-center retrospective analysis of patients with positive patch test reactions to formaldehyde 2% aq. and five FRs. RESULTS A maximum of 15 067 patients were tested to formaldehyde 2% aq. and at least one FR. The percentage of isolated reactions to FR, without co-reactivity to, formaldehyde 2% aq. for each FR were: 46.8% for quarternium-15 1% pet.; 67.4% imidazolidinyl urea 2% pet.; 64% diazolidinyl urea 2% pet.; 83.3% 1,3-dimethylol-5, 5-dimethyl hydantoin (DMDM) hydantoin 2% pet. and 96.3% 2-bromo-2-nitropropane-1,3-diol 0.5% pet. This demonstrates that co-reactivity varies between FRs and formaldehyde, from being virtually non-existent in 2-bromo-2-nitropropane-1,3-diol 0.5% pet. (Cohen's kappa: 0, 95% confidence interval [CI] -0.02 to 0.02)], to only weak concordance for quaternium-15 [Cohen's kappa: 0.22, 95%CI 0.16 to 0.28)], where Cohen's kappa value of 1 would indicate full concordance. CONCLUSIONS Formaldehyde 2% aq. is an inadequate screen for contact allergy to the formaldehyde releasers, which should be considered for inclusion in any series dependant on the frequency of reactions to and relevance of each individual allergen.
- Published
- 2021
35. Severity And Functional Disability Of Patients With Occupational Contact Dermatitis: Validation Of The German Version Of The Occupational Contact Dermatitis Disease Severity Index (ODDI).
- Author
-
Apfelbacher, C., Popielnicki, A., Bauer, A., Diepgen, T.L., Elsner, P., Dawsey, R., Mahler, V., Molin, S., Schmitt, J., Weisshaar, E., and Ofenloch, R.F.
- Subjects
- *
OCCUPATIONAL dermatitis , *SEVERITY of illness index , *PSYCHOMETRICS , *TRANSLATING & interpreting , *PHYSICIANS , *DERMATOLOGY - Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.